Carrington, E. M., Vikstrom, I. B., Light, A., Sutherland, R. M., Londrigan, S. L., Mason, K. D., . . . Tarlinton, D. M. (2010). BH3 mimetics antagonizing restricted prosurvival Bcl-2 proteins represent another class of selective immune modulatory drugs. National Academy of Sciences.

Carrington, Emma M., Ingela B. Vikstrom, Amanda Light, Robyn M. Sutherland, Sarah L. Londrigan, Kylie D. Mason, David C. S. Huang, Andrew M. Lew, and David M. Tarlinton. BH3 Mimetics Antagonizing Restricted Prosurvival Bcl-2 Proteins Represent Another Class of Selective Immune Modulatory Drugs. National Academy of Sciences, 2010.

Carrington, Emma M., et al. BH3 Mimetics Antagonizing Restricted Prosurvival Bcl-2 Proteins Represent Another Class of Selective Immune Modulatory Drugs. National Academy of Sciences, 2010.